As a corporate advisor, Dimitris helps guide the organization on digital transformation, artificial intelligence, data strategy, and innovation across the drug development lifecycle.
Dimitris has more than 30 years of experience spanning pharmaceutical R&D, biotechnology, healthcare technology, and data science. He currently serves as a Director at Arsenal Capital Partners, where he leads digital, data, and AI strategy initiatives across healthcare and life sciences investments.
Prior to Arsenal, Dimitris held senior leadership positions at Generate Biomedicines, Pfizer, Novartis, Covance/LabCorp, and Johnson & Johnson, where he helped drive the adoption of advanced technologies and data-driven decision-making across research and development organizations.
A recognized leader in computational science and digital innovation, Dimitris has authored more than 100 scientific publications, holds 18 U.S. patents, and is ranked among the world’s top 1% most-cited scientists. He was elected a Fellow of the Royal Society of Chemistry (FRSC) and has been recognized as one of Computerworld’s Premier 100 Technology Leaders.
Dimitris holds a PhD in Theoretical Chemistry from Imperial College London and completed postdoctoral fellowships at the University of California, Berkeley and Harvard University.
